FidoCure
FidoCure
Claim
FidoCure® uses genomic testing to identify possible cancer-causing mutations and then suggests targeted therapy to precisely attack the cancer cells. With FidoCure®, dogs with cancer receive access to the latest scientific advances in cancer care, from tests to treatment.FidoCure® uses genomic testing to identify possible cancer-causing mutations and then suggests targe Show More
Alpha Score
$ 10.00 M
Alpha Score
58.7
Predictions
Overview
Team
Financials- Partnerships
Relationships
Locations
Competitors
Comparison
News
Product
Regulatory
Clinical
Patent
Publications
Notes
0and0